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Letter to the Editor
Dear Sir:
We have read with interest the article by Bridge and Thijs1 fo-
cused on how selecting cryptogenic stroke patients to screen for 
atrial fibrillation (AF). 
Cryptogenic stroke is an exclusion diagnosis, which is reached 
by ruling out known causes;2 however, it is possible that a silent 
AF may play a key role in the pathogenesis of this kind of stroke.3 
In recent years, the use of prolonged outpatient cardiac monitor-
ing has led to detection of low-burden AF in 15% of cryptogenic 
stroke patients.2
Bridge and Thijs emphasize resting electrocardiographic find-
ings as simple and effective markers for selecting patients who 
should undergo further electrocardiogram (ECG) monitoring.1 
Since it is really difficult and expensive to perform prolonged 
ECG monitoring in all cryptogenic strokes, resting 12-lead ECG 
parameters could help to identify subgroups of patients to sub-
mit to further ECG monitoring.4
Nevertheless, Bridge doesn’t take account of P wave dispersion 
(PWD), a well-known ECG parameter, predictor of AF.5 PWD is 
defined as the difference between the maximum and the mini-
mum P wave duration detected in a 12-lead ECG. A standard 
12-lead ECG is generally used to measure PWD: P wave duration 
is manually measured from the beginning of the P wave deflec-
tion from the isoelectric line to the end of the deflection return-
ing to isoelectric line in all simultaneous 12 leads of a standard 
paper-printed ECG. Therefore, PWD results from the difference 
between the shortest and the longest P wave duration in any of 
the simultaneous 12 ECG leads (Figure 1). PWD can be calculat-
ed by measurements on paper or computerized methods. How-
ever, manual measurement of P wave duration is feasible, more 
stable and reliable when performed on the high-resolution 
screen of a digital ECG system: scanning and digitizing paper-
printed ECGs allow to achieve greater precision in detecting and 
measuring PWD.6
Increased PWD values reflect the inhomogeneous propagation 
of sinus impulses and the prolongation of atrial conduction time, 
a recognized electrophysiological substrate in patients with par-
oxysmal AF. PWD was proven to be a sensitive and specific ECG 
marker for the risk of AF occurrence with a cutoff value of 40 ms 
for the identification of patients with history of paroxysmal lone 
AF in comparison with healthy subjects.5 Various insults leading 
to atrial remodeling result in slowed atrial conduction with in-
homogeneous recovery, reflecting prolonged, inhomogeneous 
and anisotropic distribution of connections between atrial myo-
cardial fibers.7 PWD may be particularly relevant to cryptogenic 
stroke where high PWD values could originate from multiple in-
flammatory insults directed against atrial myocardial cells.8 In 
fact, in patients with cardioembolic stroke and paroxysmal AF, 
increased PWD values has been consistently reported (Table 1).3,9 
Furthermore, an our own previous study3 showed that PWD val-
ues in cryptogenic stroke, as well as in cardioembolic group, are 
higher in comparison with healthy subjects, suggesting that 
PWD may be a marker to identify groups of patients to submit to 
longer ECG monitoring. Similarly, in recurrent transient ischemic 
attacks, high PWD values were observed, suggesting that a 
PWD>40 msec may be linked to an underlying silent paroxysmal 
AF, possible cause of ischemic recurrence.10 Another recent stu-
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dy11demonstrated increased PWD values in cryptogenic stroke 
patients, also suggesting an association with impaired left atrial 
mechanical functions and atrial enlargement, involved in the 
pathophysiology of AF. Conflicting results were reported by a 
previous study only,12 which found no difference in PWD values 
in acute stroke patients vs. control group. However in this study, 
patients with history of AF and cardiac diseases were excluded. 
Moreover, pathogenesis of ischemic strokes was not reported.
PWD represents a promising marker of AF occurrence in these 
patients and a useful tool to identify subjects needing prolonged 
ECG monitoring; however, since these small reported studies 
didn’t evaluate the correlation between this ECG marker and fu-
ture detection of AF in cryptogenic stroke, further prospective 
studies are needed, in order to evaluate the relationship between 
PWD values and AF detection during prolonged ECG monitoring.
Finally, in our recent paper,4 we suggested that 12-lead resting 
ECG represents a great potential tool in the evaluation of pa-
tients with cryptogenic stroke, because, besides PWD, ECG may 
show other P wave indices, such as P wave duration above 120 
ms and PR interval greater than 200 ms. These indices provide 
important information on atrial electric abnormalities during si-
nus rhythm: they reflect subclinical atrial remodeling, secondary 
to the cumulative exposure to heterogeneous insults, represent-
ing a substrate for AF.
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Figure 1. Examples for measurement of P wave duration in 12 leads of two standard digitized paper-printed electrocardiogram (ECG) (A: healthy subject. B: 
patient with cryptogenic stroke). P wave duration is measured from the beginning of the P wave deflection from the isoelectric line to the end of the deflec-
tion returning to isoelectric line in all simultaneous 12 leads of ECG. P wave dispersion results from the difference between the shortest (P minimum) and the 
longest (P maximu ) P wave duration.
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